# Blood Biomarker Signature in Glioma

> **NCT03698201** · — · TERMINATED · sponsor: **Cancer Trials Ireland** · enrollment: 147 (actual)

## Conditions studied

- Glioma of Brain

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT03698201
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2021-05
- **Final completion:** 2021-05
- **Target enrollment:** 147 (ACTUAL)
- **Why stopped:** As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up.
- **Last updated:** 2025-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698201, "Blood Biomarker Signature in Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03698201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*